江苏吉贝尔药业股份有限公司监事会关于公司2025年限制性股票激励计划首次授予激励对象名单审核及公示情况的说明

Core Viewpoint - Jiangsu Jibeier Pharmaceutical Co., Ltd. has announced the approval and public disclosure of the list of incentive recipients for its 2025 restricted stock incentive plan, ensuring compliance with relevant regulations and internal governance [1][2]. Disclosure Situation - The company disclosed the draft of the 2025 restricted stock incentive plan and its summary on the Shanghai Stock Exchange website on March 29, 2025 [1]. - From March 29 to April 7, 2025, the names and positions of the first batch of incentive recipients were publicly announced internally for a period of 10 days, during which no objections were raised [2]. Verification Opinions - The supervisory board confirmed that the recipients of the incentive plan meet the conditions set forth in the relevant laws, regulations, and the draft plan, excluding supervisors and independent directors from the list [2]. - The recipients possess the necessary qualifications as per the Company Law and the company's articles of association, and do not fall under any disqualifying conditions outlined in the management regulations [2].